Overcoming the boundaries of gene editing by unlocking the full potential of recombinases.
About us
Seamless Therapeutics is changing the paradigm of gene editing through a pioneering approach to restore health in patients with severe conditions in a safe and precise manner. Our technology platform unlocks the reprogramming of recombinases, a highly versatile class of enzymes. We are applying our proprietary know-how to develop a pipeline of disease-modifying product candidates across a broad spectrum of indications to expand the therapeutic potential of gene editing.
Management Team
Seamless Therapeutics is led by an ambitious management team and an experienced board, joined by a shared vision to transform the gene editing landscape
Investors
Seamless Therapeutics is supported by leading life-science investors
